VolitionRx Limited (NYSE:VNRX) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ET Company Participants Scott Powell – Executive Vice President-Investor Relations Cameron Reynolds – President and Group Chief Executive Officer Terig Hughes – Group Chief Financial Officer Tom Butera – Chief Executive Officer-Volition Veterinary Diagnostics Development LLC Conference Call Participants Bruce Jackson – Benchmark Constantine Davides – E.F. Hutton Steven Ralston – Zacks David Westenberg – Piper Sandler Jim ...